1. Home
  2. LMND vs NAMS Comparison

LMND vs NAMS Comparison

Compare LMND & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMND
  • NAMS
  • Stock Information
  • Founded
  • LMND 2015
  • NAMS 2019
  • Country
  • LMND United States
  • NAMS Netherlands
  • Employees
  • LMND N/A
  • NAMS N/A
  • Industry
  • LMND Property-Casualty Insurers
  • NAMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LMND Finance
  • NAMS Health Care
  • Exchange
  • LMND Nasdaq
  • NAMS Nasdaq
  • Market Cap
  • LMND 2.8B
  • NAMS 2.5B
  • IPO Year
  • LMND 2020
  • NAMS N/A
  • Fundamental
  • Price
  • LMND $42.43
  • NAMS $19.85
  • Analyst Decision
  • LMND Hold
  • NAMS Strong Buy
  • Analyst Count
  • LMND 11
  • NAMS 8
  • Target Price
  • LMND $32.73
  • NAMS $42.88
  • AVG Volume (30 Days)
  • LMND 3.0M
  • NAMS 1.0M
  • Earning Date
  • LMND 07-29-2025
  • NAMS 08-06-2025
  • Dividend Yield
  • LMND N/A
  • NAMS N/A
  • EPS Growth
  • LMND N/A
  • NAMS N/A
  • EPS
  • LMND N/A
  • NAMS N/A
  • Revenue
  • LMND $558,600,000.00
  • NAMS $47,140,000.00
  • Revenue This Year
  • LMND $29.15
  • NAMS N/A
  • Revenue Next Year
  • LMND $31.39
  • NAMS N/A
  • P/E Ratio
  • LMND N/A
  • NAMS N/A
  • Revenue Growth
  • LMND 23.12
  • NAMS 586.97
  • 52 Week Low
  • LMND $14.90
  • NAMS $14.06
  • 52 Week High
  • LMND $53.85
  • NAMS $27.29
  • Technical
  • Relative Strength Index (RSI)
  • LMND 56.63
  • NAMS 57.81
  • Support Level
  • LMND $41.80
  • NAMS $17.97
  • Resistance Level
  • LMND $47.25
  • NAMS $18.97
  • Average True Range (ATR)
  • LMND 2.93
  • NAMS 1.11
  • MACD
  • LMND -0.34
  • NAMS 0.02
  • Stochastic Oscillator
  • LMND 50.82
  • NAMS 51.87

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: